
Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Targeted Search
Clinical Trials Search Results
Query: "AREA[SponsorSearch](GeneScience Pharmaceuticals Co., Ltd.)"
Count: 40
Selected: 0
NCT ID | Title |
---|
NCT01785784 | Efficacy and Safety Study of rhGM-CSF Gel to Treat Deep 2nd Thickness Burn | ||
NCT02375620 | Clinical Study of Pegylated Somatropin (PEG Somatropin) to Treat SGA Children With Short Stature | ||
NCT03245333 | A Study of Recombinant Human Growth Hormone Injection for Short Children With Small for Small for Gestational Age(SGA) | ||
NCT03221933 | A Study of Recombinant Human Growth Hormone Injection(JINTOPIN AQ)for Short Children With Small for SGA | ||
NCT03535415 | A Study to Evaluate the Efficacy and Safety of Recombinant Human Growth Hormone in Short Stature Children Due to Chronic Kidney Disease Before Transplantation | ||
NCT03189160 | A Study of PEG-somatropin Injection to Treat Children of Turner Syndrome | ||
NCT03554031 | A Study to Evaluate the Efficacy and Safety of Recombinant Human Growth Hormone Injection in Patients With Prader-Willi Syndrome | ||
NCT03635580 | Efficacy and Safety of rhGH (Jintropin®) in Pediatric Participants With ISS | ||
NCT02908958 | Clinical Study of Pegylated Somatropin to Treat Children Growth Hormone Deficiency | ||
NCT03071172 | Clinical Study of Recombinant Human Follitropin for Injection Assisted in COH Assisted IVF-ET | ||
NCT03255694 | A Study Extension Period of PEG-somatropin (Pegylated-somatropin) in the Treatment of Children With Idiopathic Short Stature | ||
NCT03221088 | A Study of PEG-somatropin in the Treatment of Children With Idiopathic Short Stature | ||
NCT03104010 | A Non-inferiority Phase 2 Study to Evaluate the Safety and Efficacy of PEG-rhGH in the Treatment of AGHD | ||
NCT04053205 | A Study of Gentuximab + Paclitaxel in Patients With Advanced Gastric or Gastroesophageal Junction Cancer | ||
NCT03249480 | Pegylated Somatropin (PEG Somatropin) in the Treatment of Children With Growth Hormone Deficiency | ||
NCT05674045 | A Phase 2, Randomized, Placebo-controlled, Double-blind Study of EG017 in Female Patients With Stress Urinary Incontinence | ||
NCT05673694 | To Evaluate a Phase Ia/Ib Clinical Study of EG017 in Patients With Advanced Breast Cancer. | ||
NCT05611281 | GS3-007a Oral Solution in Healthy Subjects | ||
NCT05441046 | Genakumab Alone and in Combination With Tislelizumab in Patients With Advanced Malignant Solid Tumors | ||
NCT05353192 | A Study to Evaluate the Efficacy and Safety of Recombinant Human Growth Hormone in Children With Achondroplasia | ||
NCT05328531 | Clinical Study of Genakumab for Injection in Patients With Acute Gout | ||
NCT05263271 | Gentulizumab in Relapsed/Refractory Acute Myelogenous Leukemia or Myelodysplastic Syndrome | ||
NCT05223595 | A Study of Gentuximab in Combination With Almonertinib in EGFR Mutation-positive Metastatic NSCLC | ||
NCT05221385 | Gentulizumab in Patients With Advanced Solid Malignancies and Non-Hodgkin Lymphoma | ||
NCT04337437 | Clinical Study of Genakumab for Injection in Chinese Healthy Volunteers | ||
NCT03313219 | Pharmacokinetics and Tolerancebility Studies of Gentuximab Injection in the Treatment ofPatients With Late Recurrence of Metastatic Solid Tumors in China | ||
NCT03290235 | Extension Study of Pegylated Somatropin to Treat Growth Retardation Caused by Endogenous Growth Hormone Deficiency in Children | ||
NCT02976675 | Pegylated Somatropin (PEG Somatropin) in the Treatment of Children With Growth Hormone Deficiency | ||
NCT02801591 | Effect of Recombinant Human Growth Hormone Injection on the Clinical Outcome of POR in Patients Undergoing IVF/ET | ||
NCT02801565 | Clinical Observation of Recombinant Human Growth Hormone Injection Assisted IVF-ET in the Treatment of PCOS | ||
NCT02380235 | Phase IV Clinical Study of Pegylated Somatropin (PEG Somatropin) to Treat Growth Hormone Deficiency Children (Clinical Trial I) | ||
NCT02335879 | Phase III Clinical Study of Domestic Recombinant Human Follitropin for Injection to Treat WHO Class II Anovulation | ||
NCT02314676 | Phase IV Clinical Study of Pegylated Somatropin (PEG Somatropin) to Treat Growth Hormone Deficiency Children | ||
NCT01613573 | Crossover Study to Assess the Safety and Pharmacokinetic of Pegylated Somatropin(PEG Somatropin) in GHD Children | ||
NCT01495468 | Phase III Clinical Study of Pegylated Somatropin (PEG Somatropin) to Treat Growth Hormone Deficiency Children | ||
NCT01342146 | Efficiency and Safety Study of Pegylated Somatropin to Treat Growth Hormone Deficiency Children | ||
NCT05144035 | A Real World Study of the Effect of Early PEG-rhGH Therapy on Cognitive Development of SGA Infants | ||
NCT05137301 | Performance of the Diagnostic Value of Bone Age Assessment Software Based on Deep Learning in Chinese Children | ||
NCT05493709 | Efficacy, Safety, and Pharmacokinetics of Leuprolide Mesylate in Subjects With Central Precocious Puberty | ||
NCT05070234 | Genetic Diagnosis and Human Growth Hormone Treatment in Small for Gestational Age Children With Short Stature |